Using First Principles to Navigate Your Cancer Journey

---

Currently, there are two predominant issues in cancer treatment: Firstly, the overall global standard of cancer treatment remains relatively low, with similar mortality rates among cancer patients worldwide, indicating minimal variation in treatment effectiveness between countries. Even in developed nations like the United States, considerable expenditure does not necessarily correlate with high treatment efficacy. Secondly, there is a prevalent problem of overtreatment, as doctors often overlook potential future side effects in pursuit of 100% cancer cell eradication, employing numerous inefficient or unnecessary treatment methods.

When evaluating the effectiveness of a cancer treatment approach, it is crucial to consider five factors: convenience, safety, inhibition rate, resistance, and sustainability. I emphasize that these five assessment factors can be deduced through a comprehensive cancer model, serving as the basis to determine the superiority of a treatment method. The optimal cancer treatment should excel in all these aspects to transform cancer into a chronic disease and extend the patient's high-quality survival period, which is the ultimate therapeutic goal humanity seeks.

My intratumoral chlorine dioxide injection therapy excels in the framework of these five evaluation factors, surpassing any currently approved cancer treatments.

I am currently researching the use of chlorine dioxide in cancer treatment (specifically intratumoral chlorine dioxide injections). Chlorine dioxide shares similar properties with the immune system tool known as ROS and has been proven to destroy cancer cells and promote tissue repair. By directly injecting chlorine dioxide into tumors, it can selectively kill cancer cells without inducing resistance, trigger immune responses, and enhance treatment efficacy. This innovative approach utilizes chlorine dioxide's ability to mimic ROS, paving the way for a new avenue in cancer treatment.

In preclinical studies and select human trials, the benefits of intratumoral chlorine dioxide therapy for cancer treatment have become apparent: 1) precise tumor targeting leading to tumor dissolution, immune response stimulation, and disruption of tumor blood vessels, resulting in higher inhibition rates; 2) minimal side effects with intratumoral injections, promoting tissue regeneration post-tumor dissolution; 3) non-resistant pathways for tumor dissolution; 4) easy injections using standard needles; 5) the only downside being minor inconvenience compared to oral or intravenous therapies, a challenge that is expected to diminish with technological advancements.

Recently, a breast cancer patient received intratumoral chlorine dioxide injections at home, and within less than a month, the tumor significantly decreased in size. In the current environment where chlorine dioxide faces widespread criticism within the medical community, I encourage cancer patients, especially those with advanced-stage cancer, to self-treat at home using my intratumoral chlorine dioxide injection method. I am willing to relinquish the patent rights for this treatment, solely focused on saving terminally ill advanced-stage cancer patients.